Severe Brain Injury Caused Dynorphin Spikes in Multiple Brain Regions
Traumatic brain injury increased dynorphin in five brain regions while other opioid peptides were unchanged — suggesting dynorphin specifically mediates secondary brain damage.
Quick Facts
What This Study Found
Severe brain injury (3.0 to 4.0 atmospheres of pressure) caused dynorphin to increase significantly in five brain regions: striatum, frontal cortex, parietal cortex, pons, and medulla. These were the same regions with the worst tissue damage.
Beta-endorphin decreased in the hypothalamus after severe injury but increased in the anterior pituitary after both mild and severe trauma. Enkephalin levels did not change at any injury level.
The dynorphin increase in the medulla was significantly correlated with falling mean arterial blood pressure after severe injury. This suggests dynorphin release may contribute to the cardiovascular collapse that worsens outcomes after head trauma.
Key Numbers
How They Did This
Cats received fluid-percussion brain injury at low (1.0 to 2.0 atm) or high (3.0 to 4.0 atm) levels. Brain regions were collected at 2 hours after injury. Dynorphin, leucine-enkephalin, and beta-endorphin were measured by immunoassay. Blood pressure was monitored throughout. Tested in cats, not people.
Why This Research Matters
This study provided the first direct measurement of opioid peptide changes after traumatic brain injury. The correlation between dynorphin and tissue damage suggested that the body's own opioid peptides might worsen brain injury, which is the rationale for testing opioid-blocking drugs like naloxone after head trauma.
The Bigger Picture
Secondary brain damage after trauma often causes more harm than the initial impact. Identifying dynorphin as a specific mediator opened doors for targeted treatments using opioid receptor blockers.
What This Study Doesn't Tell Us
Tested in cats, not people. Only measured at one time point (2 hours). The correlation between dynorphin and damage does not prove dynorphin caused the damage. It could be a consequence rather than a cause. Small sample sizes typical of large animal studies.
Questions This Raises
- ?Could dynorphin-blocking drugs reduce brain damage after head injuries?
- ?Is the dynorphin increase protective or harmful?
Trust & Context
- Key Stat:
- Dynorphin up in 5 regions Within 2 hours of severe brain injury — other opioids unchanged
- Evidence Grade:
- Preliminary animal study with two severity levels but limited to a 2-hour time point.
- Study Age:
- Published in 1987 — pioneering work linking dynorphin to traumatic brain injury pathology.
- Original Title:
- Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat.
- Published In:
- Brain research, 425(2), 225-33 (1987)
- Authors:
- McIntosh, T K(3), Head, V A, Faden, A I(3)
- Database ID:
- RPEP-00051
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is secondary brain damage?
After the initial impact, a cascade of chemical changes causes additional damage over hours to days. This secondary damage often exceeds the primary injury and is a major target for treatment.
Why does dynorphin increase after injury?
Brain injury triggers massive release of stored neuropeptides. Dynorphin appears particularly sensitive to trauma and may contribute to secondary damage by reducing blood flow and causing cell death.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00051APA
McIntosh, T K; Head, V A; Faden, A I. (1987). Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat.. Brain research, 425(2), 225-33.
MLA
McIntosh, T K, et al. "Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat.." Brain research, 1987.
RethinkPeptides
RethinkPeptides Research Database. "Alterations in regional concentrations of endogenous opioids..." RPEP-00051. Retrieved from https://rethinkpeptides.com/research/mcintosh-1987-alterations-in-regional-concentrations
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.